BioPharm International, October 2009 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International, October 2009
Features
Biopharmaceuticals: Approval Trends in 2008
By Gary Walsh, PhD
Ten biopharmaceuticals gained marketing authorization in the US or EU in 2008, although only four were new approvals.
A Closer Look at Automated In-Line Dilution
By Brandon J. Patterson
Automated in-line dilution can help solve capacity, financial, and quality concerns that biopharmaceutical manufacturing plants may be facing.
Manufacturing Economics Series
Harvesting the Benefits of LEAN in Biopharmaceutical Manufacturing
By Thibaud S. Stoll , Jean-François Guilland
A step-by-step approach is essential for successful implementation.
Regulatory Beat
FDA Leaders Stress Science and Compliance
By Jill Wechsler
Stiffer enforcement of quality standards aims to restore public confidence in agency actions.
From the Editor
Pharma and Healthcare Reform, Part 2
By Laura Bush
It seems clear that insuring the roughly 46 million Americans who are now uninsured will increase drug sales.
Final Word
Apply the "Butterfly Effect" to Streamline Your Supply Chain
By Cindy Lieberman
Small changes can have a big effect further downstream in your manufacturing processes.
Burrill on Biotech
Biotech Remains Upbeat During the Summer
By G. Steven Burrill
Biotech impressed investors with positive drug data, strong drug sales and earnings, and partnering deals.
Outsourcing Insights
Building a Turnkey Manufacturing Solution
By Jim Miller
Lonza's bid for Patheon makes the contract manufacturing industry re-examine the one-stop manufacturer model.

ADVERTISEMENT

ADVERTISEMENT

Click here